drugset / Trial / NCT07354711
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
The study is being conducted to evaluate the safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of 3H-10000 in the treatment of unresectable or metastatic solid tumors .
Timeline
- Start
- 2026-01-04
- Primary completion
- 2028-01
- Completion
- 2029-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 3H-10000 | Unknown | — | Other |